Shares of Park Ha Biological Technology slid another 7.8% to $0.33 on July 30, extending a punishing decline for the Wuxi, China-based skincare company that has been bleeding value ever since it priced a deeply discounted public offering in January. The stock has fallen roughly 17.5% in the past week alone, and the damage traces back to a single capital raise that flooded the market with new shares — and the promise of far more to come.

  • The Offering Price Was a Fraction of the Stock's Value — and Investors Noticed. Park Ha closed a best-efforts public offering of 21,875,000 units at just $0.112 per unit in late January , raising roughly $2.45 million in gross proceeds before fees.

The stock fell 31.35% in the week surrounding the announcement , reflecting the market's blunt verdict: the company was selling equity at fire-sale prices out of necessity, not strength.

  • The Real Dilution Threat Is the Warrants, Not Just the Shares. Each warrant includes a zero-exercise-price option allowing holders to receive nine Class A ordinary shares per warrant for no additional payment , registering up to 196,875,000 shares on top of 21.875 million new shares — against only 14,824,403 shares outstanding before the deal. That means the total potential share count could balloon by more than fourteen times. The company itself acknowledged it does not expect warrant holders to pay cash, meaning these exercises will generate no additional capital — pure dilution with zero offsetting benefit.

  • A Second Offering Just Weeks Ago Deepened the Hole. In June, Park Ha closed another registered direct offering, selling roughly 1.33 million shares and pre-funded warrants at $1.50 each, raising an additional $2.0 million. Two capital raises in six months for a company with less than $2.8 million in annual revenue signals chronic cash burn that store expansion alone may not fix.

  • The Financial Picture Is Deteriorating Fast. Earnings have declined roughly 89% per year over the past five years , and full-year 2025 results showed a staggering $41.38 loss per share.

Shareholders have been diluted by 111% in the past year alone. With a market cap under $5 million , Park Ha is running out of room to raise money without destroying whatever equity value remains. The stated plan — using proceeds to expand directly operated stores in China — reads more like survival spending than a growth strategy, and investors are pricing it accordingly.